More and more areas of medicine are relying on support from artificial intelligence (AI). This is particularly true for the wide range of questions based on the evaluation of image data: for example, doctors search mammograms ...
Feb 12, 2024
0
26
With the national opioid epidemic disproportionately affecting American Indians and Alaska Natives, a tribal confederation in Oregon decided to take matters into their own hands.
Jan 30, 2024
0
0
The prevalence of Alzheimer's disease and related dementias (ADRD) is disproportionately high among rural, racially/ethnically diverse older residents. In fact, they face up to an 80% greater risk of cognitive impairment ...
Jan 30, 2024
0
0
A group from teens to seniors gathered in an office inside a grocery store, where Spanish-language food signs cater to the large Hispanic population in this northwestern Georgia city dominated by the carpet industry.
Jan 24, 2024
0
0
With an election looming, the next government must have health equity at its heart to avoid more devastating and avoidable loss of lives, argues Professor Sir Michael Marmot in The BMJ today.
Jan 15, 2024
0
0
A new report from the UCL Institute of Health Equity (IHE) has confirmed that a million people in 90% of areas in England lived shorter lives than they should have between 2011 and the start of the pandemic.
Jan 8, 2024
0
0
Gov. Gavin Newsom gathered with city leaders and public safety officials Wednesday to urge support of Proposition 1, an overhaul of the state's mental health system that will be on California's March 5 primary election ballot.
Jan 4, 2024
0
7
Research Professor of Psychology and Human Development Bahr Weiss is helping to lead efforts to develop Vietnam's licensure criteria for clinical psychologists, and as part of his primary efforts at capacity development, ...
Dec 13, 2023
0
8
The future for AI regulation is currently being charted in the United States and will have significant effects on the health sciences, writes Vanderbilt researcher Laura Stark in a new article.
Dec 13, 2023
0
0
Men with hormone-resistant prostate cancer and specific genetic mutations who were treated with the PARP inhibitor drug olaparib survived longer than men treated with traditional hormone therapy, according to an analysis ...
Dec 7, 2023
0
1
